
Chinese General Practice ›› 2024, Vol. 27 ›› Issue (26): 3232-3239.DOI: 10.12114/j.issn.1007-9572.2023.0762
Special Issue: 脑健康最新研究合辑
• Original Research • Previous Articles Next Articles
Received:2023-11-10
Revised:2024-03-25
Published:2024-09-15
Online:2024-06-14
Contact:
JI Yifei
通讯作者:
季一飞
作者简介:作者贡献:
李秋伶提出主要研究目标,负责研究的构思、设计和实施,撰写、修订论文;李秋伶、唐文武进行数据的采集与整理,统计学处理,绘制与展示图表;余艺雯、邓欢进行数据的采集与整理;杨小华、陈晓霞进行数据采集;季一飞负责文章的质量控制与审查,提供监督和指导。
基金资助:CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0762
| 变量 | 未发生SBI(n=384) | 发生SBI(n=102) | 检验统计量值 | P值 |
|---|---|---|---|---|
| 性别[例(%)] | 2.073 | 0.150 | ||
| 女 | 162(42.2) | 35(34.3) | ||
| 男 | 222(57.8) | 67(65.7) | ||
| 年龄[M(P25,P75),岁] | 61.0(51.0,71.0) | 70.0(58.0,76.0) | -4.599a | <0.001 |
| 吸烟史[例(%)] | 10.267 | 0.001 | ||
| 无 | 361(94.0) | 86(84.3) | ||
| 有 | 23(6.0) | 16(15.7) | ||
| 饮酒史[例(%)] | 23.520 | <0.001 | ||
| 无 | 378(98.4) | 90(88.2) | ||
| 有 | 6(1.6) | 12(11.8) | ||
| 心脏瓣膜钙化[例(%)] | 5.524 | 0.019 | ||
| 无 | 276(71.9) | 61(59.8) | ||
| 有 | 108(28.1) | 41(40.2) | ||
| BMI[M(P25,P75),kg/m2] | 22.1(19.9,24.6) | 23.4(21.0,25.5) | -3.028a | 0.002 |
| 慢性病史[例(%)] | 17.324 | <0.001 | ||
| 无 | 198(51.6) | 29(28.4) | ||
| 有 | 186(48.4) | 73(71.6) | ||
| 冠心病[例(%)] | 0.467 | 0.494 | ||
| 无 | 302(78.6) | 77(75.5) | ||
| 有 | 82(21.4) | 25(24.5) | ||
| 心房颤动[例(%)] | 1.637 | 0.201 | ||
| 无 | 306(79.7) | 87(85.3) | ||
| 有 | 78(20.3) | 15(14.7) | ||
| 睡眠时长[例(%)] | 61.999 | <0.001 | ||
| 5~9 h/d | 339(88.3) | 55(53.9) | ||
| <5 h/d或>9 h/d | 45(11.7) | 47(46.1) | ||
| 高血压分级[例(%)] | 3.854 | 0.278 | ||
| 0级 | 56(14.6) | 11(10.8) | ||
| 1级 | 49(12.8) | 13(12.7) | ||
| 2级 | 55(14.3) | 9(8.8) | ||
| 3级 | 224(58.3) | 69(67.6) | ||
| NYHA[例(%)] | 4.471 | 0.346 | ||
| 0级 | 21(5.5) | 2(2.0) | ||
| 1级 | 6(1.6) | 1(1.0) | ||
| 2级 | 112(29.2) | 24(23.5) | ||
| 3级 | 181(47.1) | 54(52.9) | ||
| 4级 | 64(16.7) | 21(20.6) | ||
| 肺部感染[例(%)] | 0.138 | 0.710 | ||
| 无 | 310(80.7) | 84(82.4) | ||
| 有 | 74(19.3) | 18(17.6) | ||
| 透析年[M(P25,P75),年] | 6.0(3.0,34.0) | 11.0(3.0,36.0) | -0.699a | 0.474 |
| 透析原因[例(%)] | 6.409 | 0.011 | ||
| 其他 | 230(59.9) | 75(73.5) | ||
| 肾炎 | 154(40.1) | 27(26.5) | ||
| 透析时长[例(%)] | 3.399 | 0.065 | ||
| <12 h/周 | 135(35.2) | 26(25.5) | ||
| ≥12 h/周 | 249(64.8) | 76(74.5) | ||
| 血管通路[例(%)] | 0.698 | 0.404 | ||
| 动静脉内瘘 | 329(85.7) | 84(82.4) | ||
| 深静脉导管 | 55(14.3) | 18(17.6) | ||
| 残余肾功能[M(P25,P75),mL·min-1·(1.73 m2)-1] | 4.968(3.815,6.914) | 5.108(3.922,7.073) | -0.785a | 0.433 |
| 超滤率[M(P25,P75),mL/min] | 10.018(8.295,12.267) | 9.524(7.417,12.000) | 1.695a | 0.090 |
| URR[M(P25,P75),%] | 66.23(64.12,68.49) | 64.96(62.18,67.41) | 3.263a | 0.001 |
| 抗血小板药用药史[例(%)] | 9.325 | 0.002 | ||
| 无 | 331(86.2) | 99(97.1) | ||
| 有 | 53(13.8) | 3(2.9) | ||
| 红细胞压积( | 29.3±7.1 | 29.6±7.3 | -0.396b | 0.692 |
| 总胆固醇[M(P25,P75),mmol/L] | 3.81(3.11,4.60) | 3.57(2.99,4.76) | 0.608a | 0.543 |
| 三酰甘油[M(P25,P75),mmol/L] | 1.36(0.98,1.98) | 1.37(1.09,2.10) | -1.405a | 0.160 |
| 高密度脂蛋白胆固醇[M(P25,P75),mmol/L] | 1.11(0.89,1.36) | 1.01(0.84,1.29) | 2.302a | 0.021 |
| 同型半胱氨酸[M(P25,P75),μmol/L] | 28.31(24.51,33.45) | 27.39(23.06,34.31) | 0.730a | 0.466 |
| 甲状旁腺激素[M(P25,P75),ng/L] | 299.8(172.4,456.0) | 287.0(157.0,471.6) | 0.303a | 0.763 |
| 乳酸[M(P25,P75),mmol/L] | 1.75(1.34,2.28) | 1.90(1.55,2.30) | -2.034a | 0.042 |
| 血钙[M(P25,P75),mmol/L] | 2.08(1.87,2.23) | 2.07(1.83,2.20) | 0.168a | 0.867 |
| 血磷[M(P25,P75),mmol/L] | 1.63(1.22,2.12) | 1.54(1.12,2.10) | 0.679a | 0.498 |
Table 1 Comparison of baseline characteristics of MHD patients with SBI and without SBI
| 变量 | 未发生SBI(n=384) | 发生SBI(n=102) | 检验统计量值 | P值 |
|---|---|---|---|---|
| 性别[例(%)] | 2.073 | 0.150 | ||
| 女 | 162(42.2) | 35(34.3) | ||
| 男 | 222(57.8) | 67(65.7) | ||
| 年龄[M(P25,P75),岁] | 61.0(51.0,71.0) | 70.0(58.0,76.0) | -4.599a | <0.001 |
| 吸烟史[例(%)] | 10.267 | 0.001 | ||
| 无 | 361(94.0) | 86(84.3) | ||
| 有 | 23(6.0) | 16(15.7) | ||
| 饮酒史[例(%)] | 23.520 | <0.001 | ||
| 无 | 378(98.4) | 90(88.2) | ||
| 有 | 6(1.6) | 12(11.8) | ||
| 心脏瓣膜钙化[例(%)] | 5.524 | 0.019 | ||
| 无 | 276(71.9) | 61(59.8) | ||
| 有 | 108(28.1) | 41(40.2) | ||
| BMI[M(P25,P75),kg/m2] | 22.1(19.9,24.6) | 23.4(21.0,25.5) | -3.028a | 0.002 |
| 慢性病史[例(%)] | 17.324 | <0.001 | ||
| 无 | 198(51.6) | 29(28.4) | ||
| 有 | 186(48.4) | 73(71.6) | ||
| 冠心病[例(%)] | 0.467 | 0.494 | ||
| 无 | 302(78.6) | 77(75.5) | ||
| 有 | 82(21.4) | 25(24.5) | ||
| 心房颤动[例(%)] | 1.637 | 0.201 | ||
| 无 | 306(79.7) | 87(85.3) | ||
| 有 | 78(20.3) | 15(14.7) | ||
| 睡眠时长[例(%)] | 61.999 | <0.001 | ||
| 5~9 h/d | 339(88.3) | 55(53.9) | ||
| <5 h/d或>9 h/d | 45(11.7) | 47(46.1) | ||
| 高血压分级[例(%)] | 3.854 | 0.278 | ||
| 0级 | 56(14.6) | 11(10.8) | ||
| 1级 | 49(12.8) | 13(12.7) | ||
| 2级 | 55(14.3) | 9(8.8) | ||
| 3级 | 224(58.3) | 69(67.6) | ||
| NYHA[例(%)] | 4.471 | 0.346 | ||
| 0级 | 21(5.5) | 2(2.0) | ||
| 1级 | 6(1.6) | 1(1.0) | ||
| 2级 | 112(29.2) | 24(23.5) | ||
| 3级 | 181(47.1) | 54(52.9) | ||
| 4级 | 64(16.7) | 21(20.6) | ||
| 肺部感染[例(%)] | 0.138 | 0.710 | ||
| 无 | 310(80.7) | 84(82.4) | ||
| 有 | 74(19.3) | 18(17.6) | ||
| 透析年[M(P25,P75),年] | 6.0(3.0,34.0) | 11.0(3.0,36.0) | -0.699a | 0.474 |
| 透析原因[例(%)] | 6.409 | 0.011 | ||
| 其他 | 230(59.9) | 75(73.5) | ||
| 肾炎 | 154(40.1) | 27(26.5) | ||
| 透析时长[例(%)] | 3.399 | 0.065 | ||
| <12 h/周 | 135(35.2) | 26(25.5) | ||
| ≥12 h/周 | 249(64.8) | 76(74.5) | ||
| 血管通路[例(%)] | 0.698 | 0.404 | ||
| 动静脉内瘘 | 329(85.7) | 84(82.4) | ||
| 深静脉导管 | 55(14.3) | 18(17.6) | ||
| 残余肾功能[M(P25,P75),mL·min-1·(1.73 m2)-1] | 4.968(3.815,6.914) | 5.108(3.922,7.073) | -0.785a | 0.433 |
| 超滤率[M(P25,P75),mL/min] | 10.018(8.295,12.267) | 9.524(7.417,12.000) | 1.695a | 0.090 |
| URR[M(P25,P75),%] | 66.23(64.12,68.49) | 64.96(62.18,67.41) | 3.263a | 0.001 |
| 抗血小板药用药史[例(%)] | 9.325 | 0.002 | ||
| 无 | 331(86.2) | 99(97.1) | ||
| 有 | 53(13.8) | 3(2.9) | ||
| 红细胞压积( | 29.3±7.1 | 29.6±7.3 | -0.396b | 0.692 |
| 总胆固醇[M(P25,P75),mmol/L] | 3.81(3.11,4.60) | 3.57(2.99,4.76) | 0.608a | 0.543 |
| 三酰甘油[M(P25,P75),mmol/L] | 1.36(0.98,1.98) | 1.37(1.09,2.10) | -1.405a | 0.160 |
| 高密度脂蛋白胆固醇[M(P25,P75),mmol/L] | 1.11(0.89,1.36) | 1.01(0.84,1.29) | 2.302a | 0.021 |
| 同型半胱氨酸[M(P25,P75),μmol/L] | 28.31(24.51,33.45) | 27.39(23.06,34.31) | 0.730a | 0.466 |
| 甲状旁腺激素[M(P25,P75),ng/L] | 299.8(172.4,456.0) | 287.0(157.0,471.6) | 0.303a | 0.763 |
| 乳酸[M(P25,P75),mmol/L] | 1.75(1.34,2.28) | 1.90(1.55,2.30) | -2.034a | 0.042 |
| 血钙[M(P25,P75),mmol/L] | 2.08(1.87,2.23) | 2.07(1.83,2.20) | 0.168a | 0.867 |
| 血磷[M(P25,P75),mmol/L] | 1.63(1.22,2.12) | 1.54(1.12,2.10) | 0.679a | 0.498 |
| 变量 | β | SE | Wald χ2值 | OR值(95%CI) | P值 |
|---|---|---|---|---|---|
| 常量 | -1.200 | 2.081 | -0.577 | 0.301(0.005~18.409) | 0.564 |
| 年龄 | 0.027 | 0.011 | 2.385 | 1.027(1.005~1.050) | 0.017 |
| BMI | 0.079 | 0.034 | 2.322 | 1.082(1.011~1.156) | 0.020 |
| 乳酸 | 0.373 | 0.126 | 2.951 | 1.452(1.152~1.897) | 0.003 |
| URR | -0.081 | 0.026 | -3.088 | 0.922(0.875~0.970) | 0.002 |
| 饮酒史(以无为参照) | |||||
| 有 | 1.501 | 0.392 | 3.832 | 4.487(2.075~9.706) | <0.001 |
| 睡眠时长(以5~9 h/d为参照) | |||||
| <5 h/d或>9 h/d | 1.838 | 0.293 | 6.263 | 6.286(3.560~11.282) | <0.001 |
| 慢性病史(以无为参照) | |||||
| 有 | 0.628 | 0.291 | 2.158 | 1.873(1.067~3.347) | 0.031 |
| 抗血小板药用药史(以无为参照) | |||||
| 有 | -1.905 | 0.697 | -2.734 | 0.149(0.030~0.490) | 0.006 |
Table 2 Multivariate Logistic regression analysis of SBI in MHD patients
| 变量 | β | SE | Wald χ2值 | OR值(95%CI) | P值 |
|---|---|---|---|---|---|
| 常量 | -1.200 | 2.081 | -0.577 | 0.301(0.005~18.409) | 0.564 |
| 年龄 | 0.027 | 0.011 | 2.385 | 1.027(1.005~1.050) | 0.017 |
| BMI | 0.079 | 0.034 | 2.322 | 1.082(1.011~1.156) | 0.020 |
| 乳酸 | 0.373 | 0.126 | 2.951 | 1.452(1.152~1.897) | 0.003 |
| URR | -0.081 | 0.026 | -3.088 | 0.922(0.875~0.970) | 0.002 |
| 饮酒史(以无为参照) | |||||
| 有 | 1.501 | 0.392 | 3.832 | 4.487(2.075~9.706) | <0.001 |
| 睡眠时长(以5~9 h/d为参照) | |||||
| <5 h/d或>9 h/d | 1.838 | 0.293 | 6.263 | 6.286(3.560~11.282) | <0.001 |
| 慢性病史(以无为参照) | |||||
| 有 | 0.628 | 0.291 | 2.158 | 1.873(1.067~3.347) | 0.031 |
| 抗血小板药用药史(以无为参照) | |||||
| 有 | -1.905 | 0.697 | -2.734 | 0.149(0.030~0.490) | 0.006 |
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国无症状脑梗死诊治共识[J]. 中华神经科杂志,2018,51(9):692-698. DOI:10.3760/cma.j.issn.1006-7876.2018.09.006.
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
陈润霖,何土凤,陶俐均,等. 心血管危险因素对颈动脉内中膜进展的影响研究[J]. 中国全科医学,2023,26(14):1709-1715. DOI:10.12114/j.issn.1007-9572.2022.0750.
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [1] | LI Jiao, XIANG Qingwei, LIU Jinjin, PENG Lang, ZHOU Jianjie, YANG Qiong, MEI Yingbing, LIU Hui, FANG Yingsong, TAN Zihu. Development and Validation of Risk Prediction Model for Fall-related Hospitalization in Patients with Alzheimer's Disease [J]. Chinese General Practice, 2026, 29(32): 4721-4729. |
| [2] | HE Yang, YANG Rong, SHEN Can, YI Shanye, LIU Lidi, ZHAO Qian, WAN Zhi, LIAO Xiaoyang. Progress in Research on the Trajectory of Frailty and Its Influencing Factors [J]. Chinese General Practice, 2026, 29(30): 4372-4378. |
| [3] | LI Jiao, ZHOU Jianjie, PENG Lang, MEI Yingbing, TAN Zihu. Development and Validation of a Risk Prediction Model for Poor Prognosis in Alzheimer's Disease Patients with Community-acquired Pneumonia [J]. Chinese General Practice, 2026, 29(29): 4248-4257. |
| [4] | LIU Zhenyu, WANG Wendong, YAO Qing, WANG Jiangmin, CAO Wendong. Analysis of Prevalence and Influencing Factors of Cardiovascular-kidney-metabolic Syndrome among Adults in Haidian District, Beijing [J]. Chinese General Practice, 2026, 29(27): 3969-3975. |
| [5] | ZHANG Xuechao, QI Qi, WU Xinyu, HAN Quanle, LI Lei, DENG Jie, LI Cangtuo, YUE Bocheng, WU Shouling, LI Kangbo. Association between the Atherogenic Index of Plasma and New-onset Chronic Kidney Disease [J]. Chinese General Practice, 2026, 29(24): 3440-3446. |
| [6] | YUAN Hangtao, HONG Yan, YUAN Peihong, LIN Bo, CUI Xiaoyun, LI Weiwei. Interpretable Machine Learning Models for Predicting the Risk of Incident Cardiometabolic Multimorbidity in Chinese Postmenopausal Women [J]. Chinese General Practice, 2026, 29(23): 3294-3306. |
| [7] | WANG Xinliang, ZOU Nannan, CHEN Nana, WANG Xin. Analysis of Clinical Characteristics and Prognostic Risk Factors in Patients with Pulmonary Mucormycosis Complicated with Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(22): 3154-3161. |
| [8] | AN Yanhong, WANG Shidong, LI Xiaoran, GUO Jiayang, WANG Zhe, SHA Peilin, MENG Yijun, LI Xiaoxuan, SHI Xue, YU Zexing, XIAO Yonghua. Study on Risk Factors and Nomogram Prediction Model for Diabetic Kidney Disease: Based on Contrast-enhanced Ultrasound Technology [J]. Chinese General Practice, 2026, 29(21): 2995-3003. |
| [9] | SONG Zhenzhen, CHEN Yang, WANG Jiwen, LIU Huishan, SHEN Simeng, SUN Ying, CHEN Xing. Study of Maternal Risk Factors Associated with Neonatal Asphyxia in Late Preterm and Term Infants [J]. Chinese General Practice, 2026, 29(20): 2874-2878. |
| [10] | YANG Xiaofeng, LI Xianwen, WU Yanfeng, ZHANG Qian, CHEN Juan, ZHAO Fengjiao. Association of Serum Vascular Endothelial Cadherin Levels with the Risk of Post-stroke Cognitive Impairment in Patients with Acute Ischemic Stroke [J]. Chinese General Practice, 2026, 29(20): 2867-2873. |
| [11] | ZHAO Huili, LU Lina, ZHUO Ya, WANG Xin. Clinical Characteristics and Risk Factors for Recurrence of Cryptogenic Organizing Pneumonia [J]. Chinese General Practice, 2026, 29(19): 2648-2655. |
| [12] | LIU Fan, CHEN Qiuyu, LI Jing. Development and Validation of a Nighttime Hypertension Screening Model for Subclinical High-risk Populations: a Single-center Cohort Study [J]. Chinese General Practice, 2026, 29(15): 1998-2005. |
| [13] | ZHEN Rui, GU Xufang, GAO Shengwei, ZHANG Bowen, REN Zhenjuan, YANG Ruixuan. Burden of Cardiovascular Diseases Attributable to Metabolic Risk Factors in China 1990—2021 and Projected Trends from 2022 to 2035 [J]. Chinese General Practice, 2026, 29(15): 2077-2083. |
| [14] | WANG Siman, ZHANG Mengchu, LI Wen, XU Ai, XU Jin, GUO Rui, YAN Haixia. Research on the Construction of a Risk Prediction Model for Primary Hypertension with Left Ventricular Hypertrophy Based on TCM Syndromes and Pulse Graph Parameters [J]. Chinese General Practice, 2026, 29(14): 1840-1848. |
| [15] | HU Jiaqi, LI Duan, FANG Hao, FAN Xingying, DU Wei, ZHOU Hanni. Study on Predictive Model of Non-genetic Risk Factors for Hyperuricemia in a Physical Examination Cohort [J]. Chinese General Practice, 2026, 29(10): 1324-1333. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||